Cellebrite DI Ltd. reported $476M of revenue over the trailing twelve months, +19% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $476M (to FY2025). Net income: $78M, trailing twelve months to FY2025. Free cash flow: $160M, trailing twelve months to FY2025. Operating margin: 14%, trailing twelve months to FY2025.

CLBTCellebrite DI Ltd.

Technology

$11.26-36% 1Y

$11.26

$10.4452 weeks$19.56

CLBT as reported

Cellebrite DI Ltd. reported $476M of revenue over the trailing twelve months, +19% on the year before. 10 reported series are charted on this page, each one as filed.

$476M

Revenue, trailing twelve months · to FY2025 · +19% against the twelve months before

Net income: $78M
Net income · −128% year on year · trailing twelve months to FY2025
Free cash flow: $160M
Free cash flow · +30% year on year · trailing twelve months to FY2025
Operating margin: 14%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for CLBT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$476M	+19%	FY2025
Net income	$78M	−128%	FY2025
EPS	$0.31	−123%	FY2025
Gross margin	84%	n/a	FY2025
Operating margin	14%	n/a	FY2025
Net margin	16%	n/a	FY2025
ROE	16%	n/a	FY2025
ROA	8.3%	n/a	FY2025
Free cash flow	$160M	+30%	FY2025
P/E	36.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.